Skip to main content
. 2018 Jul 16;12(10):328–336. doi: 10.5489/cuaj.5378

Table 5.

Public funding approval for radium-223, docetaxel, and cabazitaxel in each province

Province Radium-223 Docetaxel Cabazitaxel
 Ontario Yes Yes Yes
 Quebec Yes Yes No
 Alberta No Yes Yes
 British Columbia Yes Yes Yes
 Saskatchewan Yes Yes Yes
 Manitoba Yes Yes Yes
 Nova Scotia No Yes Yes
 New Brunswick No Yes Yes
 Prince Edward Island No Yes No
 Newfoundland and Labrador No Yes Yes